Topical Tips: Experts on AhR Activation for Treating Psoriasis (CME/CE Monograph)
Topical Tips: Experts on AhR Activation for Treating Psoriasis (CME/CE Monograph) is organized by MedEdicus LLC.
Course opens: 04/14/2023
Course expires: 04/30/2024
Description:
Established topical therapies for psoriasis have a variety of drawbacks that impact patient adherence, satisfaction, and overall effectiveness. Two newer nonsteroidal topical agents approved by the US Food and Drug Administration have overcome many of the limitations of older topical therapies. One agent’s mechanism of action (phosphodiesterase-4 inhibition) is familiar in dermatology, but the other (aryl hydrocarbon receptor activation) is a novel mechanism. This educational activity is intended to focus on practical management tips for using the aryl hydrocarbon receptor activation agent to optimize patient outcomes as well as to provide an overview of relevant clinical data for these agents.
Learning Objectives
After completing this activity, participants will be better able to:
• Describe the mechanism of action of aryl hydrocarbon receptor agonism in the treatment of plaque psoriasis
• Review evidence on the clinical efficacy and safety of aryl hydrocarbon receptor treatment for plaque psoriasis
• Develop appropriate education and counseling strategies to achieve improved outcomes with the use of aryl hydrocarbon receptor agonism in the treatment of plaque psoriasis
Additional details will be posted as soon as information is available.